About Us
Shandong Provence Food and Drugs Administration and Shandong Provence drug side-effect center, acting as the responsible agencies for National Drug Safety “’Thirteenth-Five year’ planning medical equipment side effects investigation regarding peritoneal dialysis” project, recently revisited Emedtech. After detailed discusses, the officials and experts highly praised Emedtech as an exemplary company in the Chinese Medical industry.
Mr. Fu from the Shandong Provence Food and Drugs Administration explained in detail to Emedtech Group attending leaders about the National Drug Safety “Thirteenth-Five year” medical equipment safety and side effects investigation, and pointing out the importance to follow thoroughly the country’s guideline in regards to safety and the wish to complete the investigation around the end of 2020.
Emedtech Group is one of the initial drafters of the new National Interventional Medical Equipment Industry Standards (YY1493-2016), its PDGO automatic peritoneal dialysis machine is a globally connected peritoneal dialysis monitoring system. During the investigation meeting, general manager of Emedtech Group, Dr. Yang Tong explained in detail the intricacies of PDGO automatic peritoneal dialysis machine to the visiting officials and experts, as well as the risk management in the design, production process and quality control.
The leaders and experts of the investigation team and Emedtech Group team had an in-depth discussion about the automatic peritoneal dialysis related risks and its management. After reviewing the production pipeline of the Emedtech Group’s PDGO system, Mr. Huang of Shangdong Provence Drug side-effects investigation center claims: “Compare to what I saw here 3 years ago, Emedtech Group has improved tremendously, its product design, risk control, and quality control has all reached leading positions!”
Mr. FU also pointed out: “Peritoneal dialysis is invaluable in treatment economics for the people of the country. Emedtech Group great effort in product risk management has urged forward China’s automatic peritoneal dialysis industry. As a leading company in the automatic peritoneal dialysis industry, Emedtech Group should have the initiative to take on more social responsibility, and catalyze Chinese automatic peritoneal dialysis industry to a new height.” Chairman of Emedtech Group Mr. Zhou Shaowen told the leaders and experts of the investigation team: “Emedtech Group is a responsible and insightful Chinese company, and we will not fail everyone’s expectations!”
Mr. Huang has pointed out that in the next step of development Emedtech Group should focus on improving the analysis of remote monitored data, and the analysis of side effect trends. This way the system can really apply the advantage of a remote monitored system, and effectively lower the risk of stay-home peritoneal dialysis. At the meantime, Emedtech Group should also enhance the system’s ability to monitor side-effects and increase its ability to forecast warning of potentially dangerous events.
Emedtech Group is a Chronic Kidney Disease (CKD) minded, full production chain company. By providing fast diagnostic filtering, nutritional intervention, kidney replacement treatment, remote healthcare, and health management, we aim to provide a holistic and high-quality treatment solution for patients with Chronic Kidney Diseases. Emedtech Group strive to contribute to the effort of CKD prevention and treatment.